AU2001289849A1 - Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate - Google Patents

Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate

Info

Publication number
AU2001289849A1
AU2001289849A1 AU2001289849A AU8984901A AU2001289849A1 AU 2001289849 A1 AU2001289849 A1 AU 2001289849A1 AU 2001289849 A AU2001289849 A AU 2001289849A AU 8984901 A AU8984901 A AU 8984901A AU 2001289849 A1 AU2001289849 A1 AU 2001289849A1
Authority
AU
Australia
Prior art keywords
carnitine
granulated
preparing
mixture
magnesium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289849A
Inventor
Martin Fuhrmann
Daniel Pianzola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza AG
Original Assignee
Lonza AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza AG filed Critical Lonza AG
Publication of AU2001289849A1 publication Critical patent/AU2001289849A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A method for preparing, from at least one hygroscopic substance, mixtures that can be granulated and that have little hygroscopicity. The corresponding mixtures, especially carnitine-magnesium citrate and carnitine-magnesium hydroxycitrate, are produced.
AU2001289849A 2000-08-29 2001-08-29 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate Abandoned AU2001289849A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00118656 2000-08-29
EP00118656.8 2000-08-29
PCT/EP2001/009962 WO2002017735A2 (en) 2000-08-29 2001-08-29 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate

Publications (1)

Publication Number Publication Date
AU2001289849A1 true AU2001289849A1 (en) 2002-03-13

Family

ID=8169680

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289849A Abandoned AU2001289849A1 (en) 2000-08-29 2001-08-29 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate

Country Status (10)

Country Link
US (2) US20030176514A1 (en)
EP (1) EP1326502B1 (en)
JP (1) JP4668513B2 (en)
AT (1) ATE295690T1 (en)
AU (1) AU2001289849A1 (en)
DE (1) DE50106272D1 (en)
DK (1) DK1326502T3 (en)
ES (1) ES2242770T3 (en)
PT (1) PT1326502E (en)
WO (1) WO2002017735A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030831A1 (en) 2003-04-22 2004-10-23 Laboratorio Chimico Int Spa BASIC SALT OF TIOTIC ACID WITH L-CARNITINE.
EP1713454A4 (en) * 2003-09-11 2008-07-02 Glykon Technologies Group Llc Enteric delivery of (-)-hydroxycitric acid
WO2005089774A1 (en) * 2004-03-18 2005-09-29 Tanabe Seiyaku Co., Ltd. D-ribose for improving depression-like symptoms
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
BRPI0612611A2 (en) 2005-07-05 2010-12-07 Lonza Ag spray drying process to produce a dry carnitine powder or granulate
US20070072910A1 (en) * 2005-09-29 2007-03-29 Smith Michael L Compositions and methods for lowering plasma concentrations of low density lipoproteins in humans
TWI424840B (en) 2005-12-19 2014-02-01 Abbott Lab Use of β-hydroxy-β-methylbutyrate
CN101209975B (en) * 2006-12-29 2010-12-01 沈阳科硕营养科技有限公司 Levulorotation carnitine calcium fumarate and its preparing method and use
EP2206440A1 (en) * 2008-12-24 2010-07-14 Taminco Process for preparing a free-flowing powder containing a deliquescent quaternary ammonium compound
CN102711522B (en) 2010-01-29 2015-09-09 雅培制药有限公司 Comprise the nutrient solution of the aseptic packaging of HMB
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
ES2481865T3 (en) 2010-01-29 2014-07-31 Abbott Laboratories Nutritional emulsions comprising HMB of calcium
TWI526161B (en) 2010-06-10 2016-03-21 亞培公司 Substantially clear nutritional liquids comprising calcium hmb and soluble protein

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1153640A (en) * 1967-04-10 1969-05-29 Soc D Etudes Prod Chimique A Carnitin Salt
IT1172394B (en) * 1983-12-28 1987-06-18 Sigma Tau Ind Farmaceuti SALTS OF L-CARNITINE AND CERTAIN ALCANOIL DERIVATIVES OF L-CARNITINE AND PROCEDURE FOR THEIR PREPARATION
EP0150688B1 (en) * 1983-12-28 1987-04-22 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
CA2018137C (en) * 1989-06-14 2000-01-11 Thomas Scholl L-carnitine magnesium citrate
US5780451A (en) * 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
AU5736096A (en) 1995-05-15 1996-11-29 Sabinsa Corporation A new process for the production of potassium hydroxy citric acid, and compositions containing the potassium hydroxy cit ric acid
IT1276253B1 (en) * 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITION CONTAINING L-CARNITINE OR ALCANOIL L-CARNITINE FOR THE PREVENTION AND TREATMENT OF SOFT STATES
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
IT1291134B1 (en) * 1997-04-08 1998-12-29 Sigma Tau Ind Farmaceuti SOLID COMPOSITIONS SUITABLE FOR ORAL ADMINISTRATION INCLUDING AN ALCANOYL L-CARNITINE MAGNESIUM CITRATE
IT1290600B1 (en) * 1997-04-30 1998-12-10 Sigma Tau Ind Farmaceuti SOLID COMPOSITIONS SUITABLE FOR ORAL ADMINISTRATION INCLUDING L-CARNITINE AND ALKANOYL L-CARNITINE MAGNESIUM FUMARATE

Also Published As

Publication number Publication date
WO2002017735A2 (en) 2002-03-07
DE50106272D1 (en) 2005-06-23
US20040167219A1 (en) 2004-08-26
JP2004507479A (en) 2004-03-11
DK1326502T3 (en) 2005-08-22
US20030176514A1 (en) 2003-09-18
EP1326502B1 (en) 2005-05-18
US7230131B2 (en) 2007-06-12
ES2242770T3 (en) 2005-11-16
EP1326502A2 (en) 2003-07-16
JP4668513B2 (en) 2011-04-13
PT1326502E (en) 2005-09-30
WO2002017735A3 (en) 2002-09-12
ATE295690T1 (en) 2005-06-15

Similar Documents

Publication Publication Date Title
ZA997733B (en) Hydrazide compounds, a process for their preparation and pharmaceutical compositions containing them.
HUP0100823A3 (en) Hydrotalcite compound, process for producing the same, and agricultural film containing the same
HK1086296A1 (en) Process for producing dipeptide
HUP0003305A3 (en) Hiv protease inhibiting tetrahydro-pyrimid-2-on derivative, pharmaceutical compositions containing it and process for producing the compound
AU2001289849A1 (en) Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate
WO2002053516A3 (en) N(phenylsulphonyl)glycine derivatives and their therapeutic use
AU2002214260A1 (en) Granular composite additive for polyolefin, process for producing the same, and polyolefin composition containing the same
MXPA02006826A (en) Cell division inhibitors and process for producing the same.
ZA200105394B (en) Diphenylurea compounds, a process for their preparation and pharmaceutical composition containing them.
MY139206A (en) Pharmaceuticals compositions comprising mycophenolic acid or mycophenolate salt
AP1703A (en) Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same.
HK1054026A1 (en) Substituted piperidines, medicaments containing these compounds, and methods for the production thereof.
AU3824599A (en) Method for producing (s,s)-benzyl-2,8-diazabicyclo{4.3.0}nonane
ZA200100864B (en) Piperidine-4-sulphonamides compounds, a process for their preparation and pharmaceutical compositions containing them.
AU4652499A (en) Pyrazole-type compounds, process for producing the same and herbicides containing the same
MY141607A (en) Lactam compound
ZA200007253B (en) Process for preparing 1,4-dihydropyridine compounds.
AU1817902A (en) Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)
AU1160700A (en) Ppar gamma ligands
GB9926986D0 (en) Process for the preparation of d,l-menthol
AU5419699A (en) Methoximinophenylacetic acid amides
ZA200103065B (en) Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds, a process for their preparation and pharmaceutical compositions containing them.
AU1798200A (en) Process for producing l-erythro-(1r,2s)-2-amino-1-phenylpropan-1-ol
ZA200103064B (en) Cyclobutaindolecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them.
AU2002254887A1 (en) Process for the carbonylation of ethylenically unsaturated compounds, bidentate diphosphine composition used in this process and processes for preparation of this bidentate diphosphine composition